SEC 13F Intelligence

Empire Life Investments Inc. / CELG

Empire Life Investments Inc.’s Celgene Corp Position

Does Empire Life Investments Inc. own Celgene Corp (CELG)? Not currently — the last reported position was 295.4K shares worth $29M in Q3 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$29M
Q3 2019
Shares
295.4K
% of Portfolio
+2.46%
Quarters Held
4
position exited

Position History CELG

Reported value by quarter
Q4 ’18: $27MQ4 ’18Q1 ’19: $26MQ1 ’19Q2 ’19: $26MQ2 ’19Q3 ’19: $29MQ3 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2019295.4K$29M+2.46%
Q2 2019277.7K$26M+2.07%
Q1 2019274.5K$26M+2.17%
Q4 2018421.1K$27M+2.43%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Empire Life Investments Inc.’s full portfolio or all institutional holders of CELG.